ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate has been researched along with phytanic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kalipada, P; Lazo, O; Singh, AK; Singh, I | 1 |
| Dhaunsi, GS; Lazo, O; Ozand, P; Pahan, K; Singh, I | 1 |
2 other study(ies) available for ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate and phytanic acid
| Article | Year |
|---|---|
Phytanic acid alpha-oxidation in human cultured skin fibroblasts.
Topics: Cell Fractionation; Cells, Cultured; Coenzyme A Ligases; Epoxy Compounds; Fatty Acids; Fibroblasts; Humans; Oxidation-Reduction; Phytanic Acid; Repressor Proteins; Saccharomyces cerevisiae Proteins; Skin; Subcellular Fractions | 1992 |
Phytanic acid alpha-oxidation. Differential subcellular localization in rat and human tissues and its inhibition by nycodenz.
Topics: Adrenoleukodystrophy; Animals; Cell Fractionation; Cells, Cultured; Centrifugation, Density Gradient; Chlorides; Chondrodysplasia Punctata; Epoxy Compounds; Fatty Acids; Ferric Compounds; Fibroblasts; Humans; Hypoglycemic Agents; Iohexol; Kinetics; Liver; Microbodies; Mitochondria; Organelles; Oxidation-Reduction; Palmitic Acid; Palmitic Acids; Phytanic Acid; Rats; Rats, Sprague-Dawley; Skin; Subcellular Fractions; Zellweger Syndrome | 1993 |